NAD+ · Research brief

Are NAD+ Supplements Worth It? NAD+ vs NADH Explained

Real Peptides Research TeamEditorial

Updated September 22, 20269 min read

51 WORDS

Short answer

NAD+ and NADH are not two different compounds. They are the same dinucleotide in two oxidation states, and the plus sign refers to the positive charge carried on the nicotinamide ring, not to a potency tier, a purity grade, or a newer formulation. The two molecules differ by roughly 2 daltons.

Key takeaways

NAD+ and NADH are the same dinucleotide in two oxidation states, separated by a single hydride and roughly 2 daltons of molecular weight.
NADH absorbs at 340 nm with an extinction coefficient near 6,220 M⁻¹cm⁻¹ while NAD+ does not, which is why the pair drives most dehydrogenase assays.
The question of better NAD+ or NADH has no universal answer; the assay direction and the enzyme under study determine which form is ordered.
Nicotinamide, also called niacinamide, is an NAD+ precursor feeding the NAMPT-dependent salvage pathway, not NAD+ itself.
Accurate NAD+/NADH ratio measurement requires parallel acid and alkaline extractions, because each condition destroys the opposite form.
Research suggests orally delivered intact NAD+ is largely degraded before absorption, which is why most clinical programs study NR and NMN instead.

Our team fields this question from lab procurement staff and graduate researchers almost weekly, usually phrased as a shopping decision when it's really a chemistry decision. Here's what we've learned: the people asking are rarely confused about biochemistry. They're confused by marketing copy that treats a redox pair as a product ladder.

Which is better NAD+ or NADH?

Asking which is better NAD+ or NADH is like asking whether a charged or discharged battery is better. NAD+ (CAS 53-84-9) is the electron-accepting oxidized form. NADH (CAS 58-68-4) is the electron-carrying reduced form. Cells interconvert them thousands of times per second. Which form a laboratory sources depends on the assay, not on quality.

The comparison most people are actually making isn't better NAD+ or NADH at all. It's NAD+ versus a precursor: nicotinamide, nicotinamide riboside, or NMN. Those are chemically distinct molecules that feed into NAD+ synthesis rather than being NAD+ themselves, which is a completely different question with completely different literature behind it. What follows covers the redox chemistry that separates the two forms, why precursors dominate published research, and how labs verify and handle each compound before it ever reaches a bench.

The plus sign is a charge state, not a grade

NAD+ (nicotinamide adenine dinucleotide) accepts a hydride, meaning two electrons and a proton, at the C4 position of its nicotinamide ring. That single transfer converts it to NADH. Free-acid molecular weights sit at roughly 663 g/mol for NAD+ and 665 g/mol for NADH, which tells you how small the structural gap actually is.

The functional gap is not small. NADH absorbs strongly at 340 nm with an extinction coefficient generally cited near 6,220 M⁻¹cm⁻¹; NAD+ does not absorb meaningfully at that wavelength. Both absorb at 260 nm through the adenine ring. That one spectroscopic difference is the backbone of most dehydrogenase kinetics work, because you can watch a reaction run in real time simply by tracking absorbance climb or fall at 340 nm.

Stability splits them too. The literature describes NAD+ as relatively stable under acidic conditions and prone to degradation in alkali, with NADH behaving in the reverse. So the honest answer to whether NADH is the same as NAD+ is: same scaffold, opposite oxidation state, opposite handling profile. And NAD versus NAD+? NAD is the generic name for the dinucleotide in either form. NAD+ specifies the oxidized one. Anyone asking which is better NAD+ or NADH is really asking which oxidation state their protocol calls for.

Why precursors, not the dinucleotides, dominate published research

Nicotinamide and niacinamide are two names for the same vitamin B3 vitamer, and it is a precursor to NAD+, not NAD+ itself. So no, NAD+ is not the same as nicotinamide. Does niacinamide increase NAD+? In cell and animal models, research describes nicotinamide as a direct substrate for the salvage pathway: NAMPT converts it to nicotinamide mononucleotide (NMN), then NMNAT enzymes convert NMN to NAD+. Nicotinamide riboside enters one step downstream through NRK1 and NRK2 kinases.

The catch is that NAMPT is the rate-limiting enzyme in that pathway. Flooding a system with substrate doesn't scale output linearly, because the bottleneck sits at the enzyme, not the supply. Meanwhile NAD+-consuming enzymes run constantly: sirtuins, PARPs, and the ectoenzyme CD38 each cleave NAD+ and release nicotinamide back into the pool. The molecule is in permanent turnover.

Here's the part most explainers skip entirely. You cannot measure NAD+ and NADH from a single extraction. Acid extraction preserves NAD+ and destroys NADH; alkaline extraction does the opposite, which means a proper ratio requires two parallel extractions from the same quenched sample. Whole blood or tissue left unquenched for even a few minutes yields a ratio that reflects your handling, not the biology. That reframes the question of better NAD+ or NADH: in a real experiment, the answer is usually both, measured separately.

What 'worth it' means depends entirely on who is asking

Are NAD+ supplements worth it? Real Peptides doesn't sell supplements and doesn't provide consumption, dosing, or administration guidance of any kind, because everything in our catalog is supplied for laboratory research only. What we can speak to is what the published literature describes and what procurement due diligence looks like.

On the science: research suggests orally delivered intact NAD+ is substantially broken down before absorption, with the dinucleotide degraded to smaller nicotinamide-containing fragments. That degradation is the main reason most human clinical programs in this space have been built around nicotinamide riboside and NMN rather than NAD+ itself. Regulatory status adds another layer. NAD+, NADH, NR, and NMN are not approved drugs, and the FDA has taken the position that NMN is excluded from the dietary supplement category, a position that remains contested in the industry.

For a laboratory, the better NAD+ or NADH decision collapses into procurement questions: purity by HPLC, correct CAS number and molecular identity on the certificate, and batch-level documentation rather than a generic marketing sheet. Our team has seen more experiments compromised by an unverified vial than by choosing the wrong redox form.

Which Is Better NAD+ or NADH: A Side-by-Side Comparison

This table sets out the properties that actually differ between the two forms and what each difference means at the bench. It is the fastest way to settle whether the question of better NAD+ or NADH has any meaningful answer for a given protocol.

Property	NAD+ (oxidized form)	NADH (reduced form)	Bottom line for researchers
Chemical identity	CAS 53-84-9, free-acid MW roughly 663 g/mol, positively charged nicotinamide ring	CAS 58-68-4, free-acid MW roughly 665 g/mol, neutral reduced ring	Verify CAS and MW on the certificate before purchase; the names are close enough that listing errors happen
Redox role	Electron acceptor, the substrate for dehydrogenases running in the oxidative direction	Electron donor, the substrate for reductive reactions and the electron transport chain	Your enzyme's direction of travel decides the form, not any quality ranking between them
Detection at 340 nm	Essentially no absorbance at 340 nm; absorbs at 260 nm via adenine	Strong absorbance at 340 nm, extinction coefficient near 6,220 M⁻¹cm⁻¹	This single property underpins nearly all continuous spectrophotometric enzyme assays
Stability profile	Described as more stable in acidic conditions, degrades under alkaline conditions	Described as more stable in alkaline conditions, degrades under acidic conditions	Ratio measurements require two separate extractions, one acid and one alkali, from the same quenched sample
Typical research use	Cofactor supplementation in enzyme assays, sirtuin and PARP activity studies, salvage pathway work	Dehydrogenase kinetics, coupled assay systems, mitochondrial and redox-balance research	Neither replaces the other; labs studying redox state routinely keep both on hand

What If: NAD+ and NADH Sourcing Scenarios

What if a supplier lists only 'NAD' with no plus sign or CAS number?

Treat the listing as unresolved and request the certificate of analysis before ordering. NAD is the generic name covering both oxidation states, and a listing without CAS 53-84-9 or CAS 58-68-4 does not tell you which one is in the vial. Purity percentage alone is no help here either, because a 99% pure vial of the wrong redox form is still the wrong compound. Molecular identity verification against the CAS number is the single cheapest quality control step in the entire procurement process.

What if an NADH stock stops absorbing properly at 340 nm?

Assume oxidation and check storage conditions before assuming an assay failure. NADH is the less stable partner in the pair and oxidizes toward NAD+ on exposure to air, acid, and repeated freeze-thaw cycles, and a falling 340 nm reading is usually the first visible sign. The awkward part is that a partially oxidized stock still produces a curve, just a flatter one, so the error reads as reduced enzyme activity rather than as reagent degradation. Fresh preparation and a blank absorbance check catch this before it contaminates a dataset.

What if someone asks which NAD is best to take?

That question sits outside what we can answer, and it is worth saying so plainly. Real Peptides supplies research-use-only compounds to laboratories and researchers, so we don't give consumption guidance, comparisons of supplement products, or anything framed around personal health outcomes. What the literature supports discussing is mechanism: which molecule enters which pathway, at which enzymatic step, and with what stability profile. Anyone weighing a personal decision about NAD-related products should be having that conversation with a licensed clinician, not a research supplier.

The Unglamorous Truth About NAD+ Marketing

Here's the honest answer: most of the content ranking for better NAD+ or NADH is comparing a molecule to its own oxidation state and calling it a product review. NAD+ and NADH are not competitors. They are two readings on the same dial, and a cell that ran out of either one would be dead within seconds. The genuinely open scientific questions in this field are about precursor pharmacokinetics, NAMPT rate limitation, and CD38-driven consumption with age. Those are unresolved in the literature, and any source telling you the matter is settled is selling something rather than citing something.

Researchers comparing the two forms can review our NAD+ research overview, the catalog entries for NAD+ 100mg and NAD+ Liquid Spray 1000mg, batch documentation on our certificates of analysis page, and the wider research compound catalog. All compounds are supplied for laboratory research only and are not for human or veterinary consumption.

The framing of better NAD+ or NADH survives because a charge symbol looks like a product code, and a product code implies a hierarchy that chemistry simply doesn't support. Once you see the pair as one molecule cycling between two states, the interesting question changes shape entirely: not which form to buy, but what the ratio between them is telling you about the redox state of the tissue you're studying. That ratio is the actual signal. The two forms are just the instrument you read it with.

References

Peer-reviewed sources on NAD+ indexed in PubMed, listed for research context. Real Peptides supplies NAD+ for laboratory research use only.

NAD⁺ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing research reviews, 2026. PMID 41655607. doi:10.1016/j.arr.2026.103057
NAD(+) restores proteostasis through splicing-dependent autophagy. Autophagy, 2026. PMID 41313318. doi:10.1080/15548627.2025.2596679
Endothelial NAD(+) depletion drives vascular senescence and neuroinflammation via mtDNA-cGAS/STING-CD38 signaling in Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. PMID 42033099. doi:10.1002/alz.71423
NAD+ and Sirt5 restore mitochondrial bioenergetics failure and improve locomotor defects caused by sucla2 mutations. JCI insight, 2026. PMID 41574612. doi:10.1172/jci.insight.181812
NAD(+) depletion drives age-related monocyte hyperinflammation after stroke and is reversed by nicotinamide riboside. Journal of neuroinflammation, 2025. PMID 41299539. doi:10.1186/s12974-025-03638-6
Lactate dehydrogenase A-coupled NAD(+) regeneration is critical for acute myeloid leukemia cell survival. Cancer & metabolism, 2025. PMID 40390151. doi:10.1186/s40170-025-00392-4
FOXO1-NMNAT3 axis dysregulation promotes doxorubicin cardiotoxicity: NAD(+) replenishment as a redox-targeted antioxidant therapy. Redox report : communications in free radical research, 2025. PMID 41021886. doi:10.1080/13510002.2025.2565033
NAD+ prevents chronic kidney disease by activating renal tubular metabolism. JCI insight, 2025. PMID 40059824. doi:10.1172/jci.insight.181443

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

For laboratory research, sourcing decisions come down to purity, verified CAS identity, and batch documentation rather than product marketing. Research suggests orally delivered intact NAD+ is largely degraded before absorption, which is why most published human programs study precursors like nicotinamide riboside and NMN instead. Real Peptides supplies research-use-only compounds and gives no consumption guidance.

Real Peptides cannot answer that, because every compound we supply is research use only and we provide no dosing, administration, or consumption guidance. What the chemistry says is that NAD+ and NADH are one molecule in two oxidation states. Anyone weighing a personal decision should discuss it with a licensed clinician rather than a research supplier.

In a research context, NAD+ is a standard cofactor with well-characterised chemistry, so its value depends on whether your assay requires the oxidized form. Purity, correct CAS 53-84-9 identity, and a batch certificate determine whether a given vial is worth sourcing. Outcome claims about personal use fall outside research-use-only compounds.

No, but they are the same molecular scaffold in two oxidation states. NAD+ is the oxidized, positively charged form; NADH is the reduced form carrying an added hydride at the C4 position of the nicotinamide ring. They differ by roughly 2 daltons and behave very differently under acid and alkali.

No. Nicotinamide is a vitamin B3 vitamer and a precursor that feeds NAD+ synthesis through the salvage pathway, while NAD+ is the complete dinucleotide containing nicotinamide, ribose, two phosphates, and adenine. Nicotinamide is also the fragment released when sirtuins, PARPs, and CD38 cleave NAD+ during normal turnover.

Niacinamide is another name for nicotinamide, and research describes it as a direct substrate for NAD+ synthesis via NAMPT and then NMNAT enzymes. The relationship is not linear, because NAMPT is the rate-limiting step and NAD+-consuming enzymes run continuously. Laboratory findings in cell and animal models do not translate directly to people.

NMN, or nicotinamide mononucleotide, is a single enzymatic step upstream of NAD+. NMNAT enzymes convert NMN into NAD+ by attaching an adenylyl group. NAD+ is the finished cofactor used by dehydrogenases, sirtuins, and PARPs, while NMN is an intermediate. The two have different molecular weights, CAS numbers, and stability profiles.

Request the batch-specific certificate of analysis and check three things: the CAS number matching the form you want, the HPLC purity figure, and the identity confirmation method. A generic supplier-wide document is not batch documentation. Real Peptides publishes certificates for catalog compounds so researchers can confirm identity before committing budget.

Research-use-only compounds are intended for qualified researchers, laboratories, and institutions conducting in vitro or preclinical work. They are not supplied for human or veterinary consumption and are not approved drugs. Buyers are responsible for handling these materials under their own institutional and regulatory requirements.

The ratio reports the redox state of the compartment being measured, which single-form concentrations cannot. Cytosolic and mitochondrial ratios differ substantially because the compartments run different reactions. Measuring the ratio correctly requires parallel acid and alkaline extractions from the same rapidly quenched sample, since each condition destroys the opposite form.

NAD+ is essential to every living cell as a redox cofactor, but that biological fact says nothing about supplementation outcomes in people. The clinical literature on NAD+ and its precursors is still developing and findings are frequently hedged for good reason. Research-use-only compounds are not supplied for personal use and carry no health claims.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA